Biotech Week articles from August 2003

Biotech Week archives from August 2003

HLA-A2 peptides are targets of HLA-A2-restricted cytotoxic T cells.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines were identified by mass spectrometry and determined to be targets of HLA-A2-restricted cytotoxic T cells. According...

Mutagenic nucleotide analogs could augment the effect of hepatitis C therapy.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Mutagenic nucleotide analogs could augment the effect of hepatitis C therapy. "The recent development of in vitro hepatitis C virus (HCV) RNA replication systems has provided useful tools for...

Improved diagnostic test detects human prions; FDA approves Zemaira.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Aventis Behring LLC announced that it has developed an improved method designed to increase the sensitivity of a test to detect human prions, the infectious proteins thought to be responsible for...

Researchers zero in on new combination therapies.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Modern drug discovery hinges on the hunt for magic-bullet molecules - single drug therapies that derail disease by attacking a specific cellular target. Despite the high-profile success of drugs...

Group B streptococcal vaccine candidates identified.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Novel protein vaccine candidates against Group B streptococcal infection have been identified using alkaline phosphatase fusions. "Using an alkaline phosphatase-based genetic screening method, we...

Calcineurin/NFAT signaling requires an ITAM containing protein, CNAIP.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Immune cells appear to all express CNAIP, that contains an essential ITAM in its cytoplasmic tail that activates the calcineurin/NFAT signalling pathway. "We report in this study the identification...

New technique can reprogram adult blood cells to be heart or nerve tissue.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Scientists in London have made an important advance in growing human cells outside the body. In a recently published paper, Dr. Ilham Saleh Abuljadayel of TriStem Corp., London, describes a...

Canadian marketing, distribution agreement signed by device firms.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- ALR Technologies, Inc., (ALRT) has appointed Dosex, Inc., of Montreal as their marketing, sales, and distribution agent in Canada for their Med Reminder medication reminder devices. Jacques...

A capillary electrophoresis system is able to discern HCV quasispecies.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- A capillary electrophoresis system is able to discern HCV quasispecies. "The quasispecies nature of the hepatitis C virus (HCV) genome is central to the transmission, persistence and pathogenesis of...

Medical diagnostics company purchased by information technology company.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- ATNG, Inc., (ATNG.OB) announced that it has signed a memorandum of understanding for the purchase of a medical diagnostics company. According to Simpson, CEO, "ATNG has agreed to acquire a Memphis,...

NSAIDs may protect against colon, rectal, stomach, and ovarian cancer.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- NSAIDs may protect against colon, rectal, stomach, and ovarian cancer. According to a study from Denmark, "There is increasing evidence of an inverse association between use of nonsteroidal...

$9.5M raised at biotech firm in private placement.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that it has raised a total of $9.5 million at an average price to the company of $0.96 per share since June 1, 2003, through multiple sales transactions of...

CE Mark approval granted for prostatic stent.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AbbeyMoor Medical, Inc., announced that it has received the CE Mark approval for The Spanner Temporary Prostatic Stent for temporary use, 30 days or less, in men with bladder outlet obstruction (BOO) to...

Pharmaceutical firm reports 9.5% sales increase in second quarter.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced financial results for the second quarter ended June 30, 2003. Worldwide sales were $4.724 billion, up 9.5% from $4.315 billion in the second quarter of 2002....

Protein tyrosine phosphatase antisense conditioning involves lipid regulation.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Protein tyrosine phosphatase antisense conditioning involves lipid regulation. According to published research from the United States, "protein tyrosine phosphatases are important regulators of...

Pharmacophore model may identify new and potent CYP17 inhibitors.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Pharmacophore model may identify new and potent CYP17 inhibitors. "We report here a molecular modeling investigation of steroidal and nonsteroidal inhibitors of human cytochrome P450...

Quality control system selected for Procleix clinical trials.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AcroMetrix announced that their investigational West Nile Virus (WNV) RNA External Quality Controls were selected for use in clinical trials designed to evaluate the safety and effectiveness of a new...

Biotech firm signs agreement with Pfizer for drug profiling.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- ActivX Biosciences, Inc., announced it has entered into an agreement with Pfizer to further characterize the protein activity of a research compound currently under development at Pfizer. Under the...

Hager named to board of directors at analgesics biotech firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced the election of George V. Hager, Jr., to Adolor's board of directors. Hager, the announced chief executive officer of Genesis HealthCare Corporation, the...

Distribution agreement signed for Xolair.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AdvancePCS (ADVP) announced that its specialty pharmacy, AdvancePCS SpecialtyRx, has signed an agreement with Genentech, Inc., (DNA) to provide Xolair (omalizumab) for subcutaneous use to patients whose...

Proteomics companies complete merger.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Advanced Bio/Chem, Inc., announced the completion of the merger with Ciro International. The name of the surviving company has been formally changed to Advanced Bio/Chem, Inc. Advanced Bio/Chem will...

Promising new data from MRA trials of ferumoxytol reported.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) announced that new clinical data on ferumoxytol (Code 7228), their next-generation product in the development pipeline, were presented at the 11th scientific meeting and...

XIAP antisense oligonucleotide selected for development.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Aegera Therapeutics, Inc., and Hybridon, Inc., (HYBN.OB) have selected a XIAP antisense oligonucleotide, AEG35156/GEM640, as the development candidate. This drug candidate showed potent antitumor...

Patent granted for size selective binding of nucleic acids on magnetic particles.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, announced the issuance of Patent No. 6,534,262, for the size...

Clot-imaging agent helps detect deep vein thrombosis.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Agenix Limited announced that it has made a significant breakthrough in the detection of blood clots at Royal Brisbane Hospital. Agenix's blood clot imaging agent ThromboView successfully detected...

Pharmaceutical firm updates status of forbearance agreement.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Akorn, Inc., (AKRN) announced that its senior lenders have indicated their intention to extend the expiration date of the forbearance agreement relating to Akorn's senior debt from June 30, 2003, until...

Inhibition of carnitine palmitoyltransferase-1 decreases food intake.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreased food intake and glucose production. According to recent research from the United States and Italy, "The enzyme carnitine...

Study suggests HPV16 can skirt the immune system.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- In a large study of HIV positive women, human papillomavirus 16 (HPV16), the virus responsible for approximately half of all cervical cancers, appeared to be better at dodging the immune system than...

Rotavirus protein NSP4 induces antibody responses during natural infection.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Rotavirus nonstructural protein NSP4 induced heterotypic antibody responses during natural infection in children. According to recent research from India, "Seroconversion of immunoglobulin A (IgA)...

New antifolate demonstrates efficacy in non-small cell lung cancer patients.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced the publication of results of a clinical study conducted by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC). Their findings indicate that...

RNA interference companies join forces.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Alnylam Pharmaceuticals, Inc., and Ribopharma AG, both therapeutic RNA interference (RNAi) companies, have merged. This strategic transaction creates an international company, with the leading...

Allosensitization a problem needing resolution, tolerance induction may work.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- In heart transplants, detection of allosensitization is not very sensitive, and there are many strategies being used to try to minimize sensitization; induction of tolerance may be the best future...

$60M immunoassay agreement renewed.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AmeriNet, Inc., has renewed its immunoassay agreement with Beckman Coulter, Inc., (BEC). The 3-year contract, valued at $60 million, became effective June 1, 2003. The renewal includes pricing...

Favorable decision issued on Taxol patent case.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Sheppard, Mullin, Richter & Hampton reported that Joe Coyne and Phil Davis, both partners in the firm's business trial practice group, obtained a favorable decision from the U.S. Court of Appeals for...

High blood pressure is on the rise in U.S.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- The American Kidney Fund (AKF) is concerned by the findings of a newly-released study indicating that the prevalence of hypertension (high blood pressure) in the United States is going up, reversing a...

Paralysis foundation provides grant for syringomyelia study.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- The American Syringomyelia Alliance Project, Inc., (ASAP) announced that it has been awarded a $25,000 Quality of Life Grant from the Christopher Reeve Paralysis Foundation (CRPF). The Quality of...

Collaboration leads to new platform for data management, integration.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Amersham Biosciences, the life sciences business of Amersham (AHM), and geneticXchange, a provider of data access and integration solutions, have collaborated to provide a powerful laboratory data...

Dere named VP, global inflammation clinical development.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) announced the appointment of Willard Dere to the position of vice president and head of the inflammation therapeutic area, one of the company's three core research and development programs....

Harvey named VP of quality assurance at pharmaceutical firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) announced that Joni Harvey has joined the company as VP of quality assurance. Harvey joins Amylin Pharmaceuticals from Alliance Pharmaceutical Corp., where she...

Soft-Vu 4F High Flow angiographic catheters launched.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AngioDynamics, Inc., a wholly owned subsidiary of E-Z-EM, Inc., (EZM) announced the introduction of Soft-Vu 4F High Flow Angiographic Catheters-an innovative line of catheters that is used in diagnostic...

AMD-3100 granted orphan drug designation.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced it has received orphan drug designation for AMD-3100, a potential new agent in stem cell transplant in cancer patients from the U.S. Food and Drug Administration (FDA)....

Private equity placement yields $2M for drug delivery company.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that it completed a $2.0 million private placement of common equity at the July 3, 2003, closing price of $1.00 per share. This placement constitutes a second...

European Union grants orphan drug status for G17DT.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Aphton Corporation (APHT) announced that the European Union has granted Orphan Drug status for Aphton's anti-gastrin immunogen G17DT, also known as G17(9)DT, for treatment of both pancreatic cancer and...

Rat genomic assays available for real-time gene expression analysis.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Applied Biosystems Group (ABI), an Applera Corporation business, announced the initial release of pre-formulated gene expression assays for researchers studying the rat, an important animal model used...

Shelf registration statement filed; data on blood cancer therapy released.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Ariad Pharmaceuticals, Inc., (ARIA) announced that it has filed a shelf registration statement with the U.S. Securities and Exchange Commission (SEC) for the issuance of up to 7.5 million shares of...

Myopericarditis is potential adverse reaction to smallpox vaccination.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Clinicians involved in smallpox vaccination programs should be aware of myopericarditis as a potential adverse reaction, according to a report in the...

Antiangiogenic cancer therapy studied in broad range of tumor models.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- New research data for two of AstraZeneca's investigational anti-vascular cancer therapies were presented at the American Association for Cancer Research (AACR) held in Washington, DC. The data...

FDA panel recommends approval of Crestor (rosuvastatin calcium).
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- AstraZeneca Pharmaceuticals (AZN) announced that the Endocrinologic and Metabolic Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously to recommend approval for Crestor...

PCR assay provides fast, simple, and accurate tuberculosis diagnosis in HIV-negative patients.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- A PCR assay provides fast, simple and accurate diagnosis of tuberculosis in HIV-negative patients. "Tuberculosis is still one of the most important cause of mortality and morbidity in many...

LabCorp and Atherotech to offer VAP Cholesterol Test.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Laboratory Corp. (LabCorp) of America Holdings (LH) has entered into a marketing and distribution relationship with Atherotech, a cardiodiagnostic company and specialty reference laboratory, to offer...

Beta cell MHC class I is a late requirement for diabetes.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Beta cell MHC class I is a late requirement for the development of diabetes. According to a study from Australia, "Type 1 diabetes occurs as a result of an autoimmune attack on the insulin-producing...

Ribozymal targeting of hepatitis C virus could include several sites.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Ribozymal targeting of hepatitis C virus could include several sites. "Accessibility to folded RNA and low potential of variation in the target RNA are crucial requirements for ribozyme therapy...

Data presented on new class of anticancer compounds.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) said its experimental compound AVP-893 showed selective growth inhibition against a variety of cancer cell lines in preclinical testing and early compound screening...

Antisense drug for West Nile manufactured for clinical trials.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Avi BioPharma, Inc., (AVII) announced that it has completed manufacturing of several lots of its West Nile virus Neugene antisense drug, Avi-4020, at its new manufacturing facility in Corvallis, Oregon....

Trial to be initiated for drug with promising cancer fighting abilities.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BTG announced plans for the further development of a potential treatment for gastrointestinal cancers such as gastric and pancreatic. The drug, BGC 9331, which is a non-polyglutamatable thymidylate...

$25M raised by catheter maker; new CEO named.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Bacchus Vascular announced that it has secured $25 million in a Series D financing led by Warburg Pincus LLC, a private equity investor in healthcare. Other participants in the round included DeNovo...

Voluntary recall issued for Nortrel 7/7/7 - 28 day.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) announced that it is initiating a voluntary recall of three lots of its Nortrel 7/7/7 - 28 day (norethindrone and ethinyl estradiol tablets, USP) oral contraceptive...

Dermatology company in-licenses oral Vitamin D3 derivative.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Barrier Therapeutics, Inc., has completed a licensing agreement with the Research Institute for Medicine and Chemistry (RIMAC) in Cambridge, Massachusetts, a firm with a history of innovation in...

Renal services components to be sold by pharmaceutical firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation announced that it has signed definitive agreements to sell its U.S.-based RMS Lifeline access management and RMS Disease Management businesses and has closed the first in a...

Fusogenic genes potentiate the effects of oncolytic virus in tumors.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Fusogenic genes potentiate the effects of oncolytic virus in tumors. "Oncolytic viruses have shown considerable promise in the treatment of solid tumors, but their potency must be improved if their...

Duration of diabetes affects circadian variation in onset of heart attack.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- The duration of diabetes affects the circadian variation in the onset of myocardial infarction. According to recent research from the United States, "There are conflicting reports regarding...

Obesity greatest among older adults in the Spanish population.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Results from a large study indicate that the prevalence of adult obesity in Spain is high, especially among women and older adults, according to a...

NIH grant provided for development of hepatitis C inhibitors.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (BCRX) announced that is has been awarded a phase I Small Business Innovation Research (SBIR) Advanced Technology Grant from the National Institute of Allergy and...

Nanobiotech firm announces scientific advisory board.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BioForce Nanosciences, Inc., has announced the formation of a scientific advisory board to assist in the scientific leadership and direction of the company. BioForce Nanosciences welcomed...

Allergy drug maker acquires biotech firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BioGentech Corp., has completed a reverse triangular merger whereby BioGentec, Inc., a Nevada corporation, became a wholly owned subsidiary. BGTH will now operate the business of BioGentec, and...

Patients to be enrolled in phase III trial of Aryplase.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced that it is set to enroll patients in its phase III trial of Aryplase (arylsulfatase B) in Mucopolysaccharidosis VI (MPS VI). The phase III trial...

OncoVEX plus chemotherapeutics lowers dose necessary to kill tumor cells.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- BioVex announced that the combination of BioVex's proprietary oncolytic agent, OncoVEX, with first line chemotherapeutic agents resulted in significant lowering of the dose of drug needed to achieve...

IM administration data: Amevive provides relief for a median of 7 months.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced data about the effect of its drug Amevive (alefacept) that show that one 12-week course of Amevive administered via intramuscular (IM) injection provided a median duration...

Series A funding secured; Kees Been named CEO.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Bionaut Pharmaceuticals, Inc., announced the expansion of its series A financing to $6.8 million and the appointment of Kees Been as CEO. Kees joins Bionaut from Biogen to lead the company's...

Marketing agreement signed with distributor.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Biosensors International announced that it has entered into a marketing agreement with DeRoyal to expand distribution of its lines of critical care products. Under the agreement, DeRoyal,...

New French subsidiary launched by device company.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE) announced the launch of a new subsidiary, Biosite France SAS, which will manage direct sales and distribution of Biosite's products in France. Tobias Volker, general...

Study: HIV treatment regimens containing Viramune or efavirenz comparable.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Treatment regimens with either Viramune (nevirapine) or efavirenz provide comparable antiviral efficacy in the early treatment of HIV infection, according to an analysis that compared the two in...

Schumacher to provide consulting services to device firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., (BBII) announced that Richard T. Schumacher, its former CEO and chairman, has agreed to accept an engagement with the company as an executive consultant with the assignment to...

Glycation end products play role in slow bone healing in type 1 diabetes.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Advanced glycation end products play a role in the diminished bone healing found in patients with type 1 diabetes. "The effect of type 1 diabetes on bone healing and bone formation in standardized...

Polymorphisms of insulin-degrading enzyme gene linked to type 2 diabetes.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Results from the NHLBI Framingham Heart Study indicate that polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes. "Linkage studies have mapped a susceptibility gene...

Pulmonary side population cells characterized.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- The features of pulmonary side population (SP) cells have been determined. SP cells "are a rare subset of cells found in various tissues that are highly enriched for stem cell activity," researchers...

Record 2Q revenue expected; scientific advisory board formed at device firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Bovie Medical Corporation (BOVI) announced that it expects to report record revenues and continued profitability for both its second quarter and 6 month periods when compared to the same periods last...

C. Ralph Daniel added to board of directors at pharmaceutical firm.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BDY) announced that C. Ralph Daniel, III, MD, has been appointed to Bradley's board of directors. Daniel brings more than 25 years of experience in the field of...

Common antioxidant may decrease risk.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Researchers believe that higher total cysteine levels may be associated with a lower risk of breast cancer, according to a study presented July 14, 2003, at the 94th Annual Meeting of the American...

Once-daily protease inhibitor approved by FDA for use in combination therapy.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced that the U.S. Food and Drug Administration (FDA) has granted marketing clearance for Reyataz (atazanavir sulfate), an azapeptide protease inhibitor indicated...

VEGFR-2 maintains hematopoietic progenitor cell survival.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- VEGFR-2 maintains hematopoietic progenitor cell survival. "Vascular endothelial growth factor (VEGF) and its receptors play an essential role in the formation and maintenance of the hematopoietic...

Dedicated surgical cohort facility dramatically improves MRSA control.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Surgical facilities dedicated to staphylococcal control can dramatically reduce the infection risk for patients. Researchers in France conducted a retrospective study "to determine whether or not a...

Early stages of beta-cell deficiency indicated by hyperinsulinism.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Early stages of beta-cell deficiency are indicated by hyperinsulinism and a high proinsulin/insulin ratio. "Type 2 diabetes combines two mechanisms, peripheral insulin resistance and beta-cell...

Sexual behavior may reduce hypothalamic receptor for androgen, not androgens.
August 6, 2003... 2003 AUG 6 - (NewsRx.com & NewsRx.net) -- Reduction of brain receptors for androgens, but not serum androgens, may occur with male sexual satiety. "Male sexual behavior is regulated by limbic areas like the medial preoptic nucleus (MPN),...